ARCA biopharma, Inc. (ABIO) Social Stream
ARCA biopharma Inc (ABIO) Price Targets From Analysts
Use the tables below to see what analysts covering ARCA biopharma Inc think about its future price and what recommendations they have for investors and traders.
Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|
1 | $7 | $7 | $7 | $2.68 | 161.19% |
Price Target Last Issued February 23, 2021
The Trend in the Analyst Price Target
Over the past 52 days, ABIO's average price target has gone down $0.
Over the past 42 weeks, ABIO's average upside potential has been 59.82%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-02-23 | 1 | 7 | 7 | 7 | 4.68 | 49.57% |
2021-02-20 | 1 | 7 | 7 | 7 | 4.75 | 47.37% |
2021-02-13 | 1 | 7 | 7 | 7 | 5.18 | 35.14% |
2021-02-06 | 1 | 7 | 7 | 7 | 4.66 | 50.21% |
2021-01-30 | 1 | 7 | 7 | 7 | 4.20 | 66.67% |
2021-01-23 | 1 | 7 | 7 | 7 | 4.66 | 50.21% |
2021-01-16 | 1 | 7 | 7 | 7 | 4.45 | 57.3% |
2021-01-09 | 1 | 7 | 7 | 7 | 4.22 | 65.88% |
2021-01-02 | 1 | 7 | 7 | 7 | 4.01 | 74.56% |
2020-12-26 | 1 | 7 | 7 | 7 | 4.25 | 64.71% |
2020-12-19 | 1 | 7 | 7 | 7 | 4.00 | 75% |
2020-12-09 | 1 | 7 | 7 | 7 | 4.12 | 69.9% |
2020-12-07 | 1 | 7 | 7 | 7 | 4.09 | 71.15% |
2020-05-04 | 1 | 7 | 7 | 7 | NA | NA% |
ABIO Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABIO has a greater number of analysts covering the stock than nearly none of all US stocks.
- ARCA biopharma Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
- The average analyst price target of ABIO is higher than 12.73% of all US stocks.
- The upside potential (average analyst target price relative to current price) of ABIO is greater than 86.93% of all US stocks.
Make investment decisions regarding ABIO using the data that counts. Try POWR Ratings for free.